Financial Daily from THE HINDU group of publications
Tuesday, Mar 16, 2004

News
Features
Stocks
Cross Currency
Shipping
Archives
Google

Group Sites

Corporate - Corporate Governance


`Cos must go beyond ethical minimum'

Our Bureau

Mumbai , March 15

IT'S a different sort of feelgood; some 40 per cent of consumers in the US buy from companies that make them feel good to deal with, work with and buy from, according to Dr Klaus Leisinger, President and Executive Director, Novartis Foundation for Sustainable Development (NFSD).

And that `feelgood' factor comes only when companies push beyond the legalities or the `ethical minimum' and take a serious look at what stakeholders expect from the company.

"Listen to your stakeholders, you will be enlightened," he told a gathering that had a sprinkling of corporate representatives brought together by the Indo-American Society.

On priorities, he said that despite the high prevalence of HIV/AIDS in sub-Saharan Africa, the Government was allocating more to military than to drugs.

On a global scale, the spend on weapons is about $900 billion, while developmental assistance is about $50 billion; protectionist support on agriculture in developed countries is to the tune of $365 billion and "a European cow gets five times more support that an African child."

He urged companies to take into account all segments affected by companies' activities, including NGOs, when working on a company framework for corporate social responsibility.

NGOs are also under pressure with the flow of funds getting limited and they would increasingly have to deal more effectively with their funds.

Big pharma companies have bad image problems, he said, since they are seen as "greedy" people making profits off people's diseases.

He underlined the need to communicate the intricacies of intellectual property and issues related to it.

More Stories on : Corporate Governance

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page



Stories in this Section
BPCL to halve product offtake from Reliance


Ranbaxy gets tentative USFDA nod for hypertension drug
L&T bags Rs 70-cr hotel deal in Bahrain
CAs told to hone up IT skills
RBI nod for $473.21 m ECBs
Nestle: Sales up; but profit growth lukewarm
`Cos must go beyond ethical minimum'
`Cos should adopt corporate governance ratings'
REL to call for gas supply bids for UP power project
Alacrity Housing staff on strike seeking wages
Ludlow Jute Mills may reopen next month
Kochi Refineries signs production pact with BPCL
Marico Industries declares 1:1 bonus
Shareholder files affidavit against L&T-Grasim deal
GM upbeat on Tavera prospects
Zydus plea to allow import of Pekin duck eggs
Getz, Elantra launch plans on track: Hyundai
BHPV chief resigns on `health grounds'



The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | Business Line | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright © 2004, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line